Generic Drugmakers Lose Bid to Block California Competition Law (1)

July 24, 2020, 7:06 PMUpdated: July 24, 2020, 8:39 PM

A California law that punishes drugmakers who pay to keep generic competitors off the market will stand after the Ninth Circuit ruled the generic companies challenging the law failed to show it would harm them.

The Association for Accessible Medicines, a lobbying group for the generic drug industry, sought to overturn a lower court decision denying an injunction to block the law. But the U.S. Court of Appeals for the Ninth Circuit ruled Friday that the district court must dismiss the case without prejudice.

The decision was a blow to the generic drugmaker group, which maintains that its members rely ...

To read the full article log in. To learn more about a subscription click here.